Annual revenue:
$233.18M+$87.94M(+60.55%)Summary
- As of today (September 16, 2025), TVTX annual revenue is $233.18 million, with the most recent change of +$87.94 million (+60.55%) on December 31, 2024.
- During the last 3 years, TVTX annual revenue has risen by +$5.68 million (+2.50%).
- TVTX annual revenue is now at all-time high.
Performance
TVTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$114.45M+$32.72M(+40.03%)Summary
- As of today (September 16, 2025), TVTX quarterly revenue is $114.45 million, with the most recent change of +$32.72 million (+40.03%) on June 30, 2025.
- Over the past year, TVTX quarterly revenue has increased by +$60.33 million (+111.49%).
- TVTX quarterly revenue is now at all-time high.
Performance
TVTX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$333.87M+$60.33M(+22.06%)Summary
- As of today (September 16, 2025), TVTX TTM revenue is $333.87 million, with the most recent change of +$60.33 million (+22.06%) on June 30, 2025.
- Over the past year, TVTX TTM revenue has increased by +$156.22 million (+87.94%).
- TVTX TTM revenue is now at all-time high.
Performance
TVTX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TVTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.5% | +111.5% | +87.9% |
| 3 y3 years | +2.5% | +111.3% | +46.4% |
| 5 y5 years | +33.0% | +136.3% | +78.3% |
TVTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.0% | at high | +307.6% | at high | +134.3% |
| 5 y | 5-year | at high | +113.0% | at high | +307.6% | at high | +134.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
TVTX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $114.45M(+40.0%) | $333.87M(+22.1%) |
| Mar 2025 | - | $81.73M(+9.3%) | $273.53M(+17.3%) |
| Dec 2024 | $233.18M(+60.5%) | $74.79M(+18.9%) | $233.18M(+14.6%) |
| Sep 2024 | - | $62.90M(+16.2%) | $203.45M(+14.5%) |
| Jun 2024 | - | $54.12M(+30.8%) | $177.64M(-3.0%) |
| Mar 2024 | - | $41.37M(-8.2%) | $183.22M(+6.1%) |
| Dec 2023 | $145.24M(+32.7%) | $45.06M(+21.5%) | $172.74M(+10.0%) |
| Sep 2023 | - | $37.09M(-37.9%) | $157.02M(+6.1%) |
| Jun 2023 | - | $59.70M(+93.3%) | $148.00M(+3.9%) |
| Mar 2023 | - | $30.89M(+5.3%) | $142.47M(-11.0%) |
| Dec 2022 | $109.46M(-51.9%) | $29.34M(+4.5%) | $160.07M(-14.8%) |
| Sep 2022 | - | $28.07M(-48.2%) | $187.98M(-17.6%) |
| Jun 2022 | - | $54.17M(+11.7%) | $228.12M(-0.2%) |
| Mar 2022 | - | $48.49M(-15.3%) | $228.57M(+0.5%) |
| Dec 2021 | $227.49M(+14.7%) | $57.25M(-16.1%) | $227.49M(+2.8%) |
| Sep 2021 | - | $68.22M(+24.9%) | $221.22M(+8.4%) |
| Jun 2021 | - | $54.62M(+15.2%) | $204.15M(+3.1%) |
| Mar 2021 | - | $47.41M(-7.0%) | $197.96M(-0.2%) |
| Dec 2020 | $198.32M(+13.1%) | $50.98M(-0.3%) | $198.32M(+2.2%) |
| Sep 2020 | - | $51.14M(+5.6%) | $194.03M(+3.6%) |
| Jun 2020 | - | $48.43M(+1.4%) | $187.26M(+2.0%) |
| Mar 2020 | - | $47.77M(+2.3%) | $183.54M(+4.7%) |
| Dec 2019 | $175.34M(+6.8%) | $46.69M(+5.2%) | $175.34M(+1.7%) |
| Sep 2019 | - | $44.37M(-0.7%) | $172.42M(+2.2%) |
| Jun 2019 | - | $44.71M(+13.0%) | $168.75M(+2.0%) |
| Mar 2019 | - | $39.57M(-9.6%) | $165.38M(+0.7%) |
| Dec 2018 | $164.25M(+6.0%) | $43.77M(+7.5%) | $164.25M(+1.0%) |
| Sep 2018 | - | $40.71M(-1.5%) | $162.65M(+0.2%) |
| Jun 2018 | - | $41.34M(+7.6%) | $162.29M(+1.6%) |
| Mar 2018 | - | $38.43M(-8.9%) | $159.75M(+3.1%) |
| Dec 2017 | $154.94M | $42.18M(+4.6%) | $154.94M(+3.2%) |
| Sep 2017 | - | $40.34M(+4.0%) | $150.09M(+4.5%) |
| Jun 2017 | - | $38.80M(+15.4%) | $143.69M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $33.62M(-9.9%) | $138.20M(+3.5%) |
| Dec 2016 | $133.59M(+33.7%) | $37.33M(+10.0%) | $133.59M(+5.4%) |
| Sep 2016 | - | $33.95M(+1.9%) | $126.71M(+4.9%) |
| Jun 2016 | - | $33.31M(+14.8%) | $120.77M(+8.3%) |
| Mar 2016 | - | $29.01M(-4.7%) | $111.53M(+11.6%) |
| Dec 2015 | $99.89M(+254.2%) | $30.45M(+8.7%) | $99.89M(+19.6%) |
| Sep 2015 | - | $28.00M(+16.4%) | $83.53M(+30.8%) |
| Jun 2015 | - | $24.07M(+38.5%) | $63.87M(+40.2%) |
| Mar 2015 | - | $17.37M(+23.3%) | $45.55M(+61.5%) |
| Dec 2014 | $28.20M(>+9900.0%) | $14.09M(+68.7%) | $28.20M(+99.8%) |
| Sep 2014 | - | $8.35M(+45.4%) | $14.12M(+144.7%) |
| Jun 2014 | - | $5.74M(>+9900.0%) | $5.77M(>+9900.0%) |
| Mar 2014 | - | $27.90K(>+9900.0%) | $27.90K(>+9900.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2008 | - | $0.00 | $0.00 |
| Feb 2008 | $0.00 | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual revenue?
- What is the all time high annual revenue for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual revenue year-on-year change?
- What is Travere Therapeutics, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Travere Therapeutics, Inc. TTM revenue?
- What is the all time high TTM revenue for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM revenue year-on-year change?
What is Travere Therapeutics, Inc. annual revenue?
The current annual revenue of TVTX is $233.18M
What is the all time high annual revenue for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual revenue is $233.18M
What is Travere Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, TVTX annual revenue has changed by +$87.94M (+60.55%)
What is Travere Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of TVTX is $114.45M
What is the all time high quarterly revenue for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly revenue is $114.45M
What is Travere Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, TVTX quarterly revenue has changed by +$60.33M (+111.49%)
What is Travere Therapeutics, Inc. TTM revenue?
The current TTM revenue of TVTX is $333.87M
What is the all time high TTM revenue for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM revenue is $333.87M
What is Travere Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, TVTX TTM revenue has changed by +$156.22M (+87.94%)